SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-073856
Filing Date
2023-12-29
Accepted
2023-12-29 16:30:18
Documents
2
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7331
2 EX-24.1 nams-ex24_1.htm EX-24.1 15118
  Complete submission text file 0000950170-23-073856.txt   23982
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Kling Douglas F (Reporting) CIK: 0001699022 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41562 | Film No.: 231528073

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)